Filter
363
Filtered Results: 363
Text search:
National
Pharmacovigilance
Policy
Featured
Recommendations
44
New Publications
126
Language
Document type
No document type
204
Guidelines
58
Studies & Reports
46
Strategic & Response Plan
21
Manuals
18
Fact sheets
7
Training Material
5
Situation Updates
3
Infographics
1
Countries / Regions
Kenya
21
Nigeria
15
India
15
Ghana
14
Uganda
14
Western and Central Europe
13
Global
11
Eastern Europe
11
Nepal
10
Rwanda
10
South Africa
10
Namibia
9
Sierra Leone
7
Malawi
7
Ethiopia
7
Tanzania
6
Philippines
5
Congo, Democratic Republic of
5
South–East Asia Region
5
Liberia
5
Cambodia
4
West and Central Africa
4
Bangladesh
4
Russia
4
Zambia
4
Lesotho
3
Benin
3
Senegal
3
Zimbabwe
3
Mozambique
3
Latin America and the Carribbean
3
East and Southern Africa
3
Botswana
3
Ukraine
2
Syria
2
Africa
2
Haiti
2
Asia
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Sudan
2
Libya
2
Indonesia
2
Myanmar / Burma
2
Madagascar
2
Eswatini/ Swaziland
2
Pakistan
2
Thailand
1
Gambia
1
Cameroon
1
Laos
1
Burkina Faso
1
Afghanistan
1
Guinea
1
Jordan
1
Western Pacific Region
1
Maldives
1
Lebanon
1
Sri Lanka
1
Yemen
1
Georgia
1
Mali
1
Bhutan
1
Authors & Publishers
Publication Years
Category
Countries
187
Clinical Guidelines
44
Public Health
12
Women & Child Health
6
Capacity Building
5
Key Resources
5
Pharmacy & Technologies
4
Toolboxes
TB
45
Pharmacy
40
AMR
31
COVID-19
23
HIV
17
NTDs
15
NCDs
4
Ebola & Marburg
3
Specific Hazards
2
Refugee
2
Caregiver
2
Planetary Health
2
Rapid Response
1
Cholera
1
Malaria
1
Polio
1
Global Health Education
1
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Drug registration in Kenya started in 1982; the process mainly involves an evaluation committee at the Kenya Pharmacy and Poisons Board (PPB) that aims to approve products based on quality, safety and efficacy.
Nepal has only recently started its journey on the path to an integrated response to the challenge of antimicrobial resistance (AMR). Despite this, it is notable that the Nepal Health Sector Strategy Plan (HSSP)-2 mentions growing antibiotic resistanceas a public health challenge.
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
Antimicrobial resistance (AMR) is an important public health concern shared by developed and developing countries. In developing countries the burden of infectious diseases is greater and exacerbated by limited access to, and availability and affordability of, antimicrobials required to treat infect...
17–24 November 2015
9 April 2020
WHO has published the guidance “Clinical management of severe acute respiratory infection (SARI) when COVID-19 disease is suspected” This document is intended for clinicians taking care of hospitalized adult and paediatric patients with severe acute respiratory infection (SARI) whe...
The WHO Cholera Vaccine Position Paper (August 2017) highlights the importance of oral cholera vaccines (OCVs) as a key tool in outbreak response and prevention, alongside water, sanitation, and hygiene (WASH) measures. It recommends OCVs for high-risk populations, endemic areas, and humanitarian cr...
Pharmaceutical profile of DRC
Framework for implementation.
The END TB Strategy.
The WHO Pharmaceuticals Newsletter provides you with the latest information on the safety of medicinal products and regulatory actions taken by authorities around the world.
In addition, this edition includes summary and recommendations from the virtual meeting of the members of the WHO Programme f...
This Pharmaceutical Country Profile for Kenya (2010) has been developed by the Ministry of Medical Services with support of the World Health Organization. The Profile contains information on existing socio-economic and health-related conditions, resources, regulatory structures and processes and out...
Mem Inst Oswaldo Cruz, Rio de Janeiro, Vol. 117: e200460, 2022
Integrating the multiple dimensions of the problem into a coherent approach adapted to field realities and needs represents an immense challenge, but the payoff is more effective and sustainable experiences, with higher social awareness...
